These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 35221278)

  • 1. Recent advances in techniques for enhancing the solubility of hydrophobic drugs.
    Xu Z; Lin S; Li Q; Jiang S; Wang P
    Pak J Pharm Sci; 2022 Jan; 35(1):95-112. PubMed ID: 35221278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved dissolution behavior of lipophilic drugs by solid dispersions: the production process as starting point for formulation considerations.
    Srinarong P; de Waard H; Frijlink HW; Hinrichs WL
    Expert Opin Drug Deliv; 2011 Sep; 8(9):1121-40. PubMed ID: 21722000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent studies on the processes and formulation impacts in the development of solid dispersions by hot-melt extrusion.
    Tran PHL; Lee BJ; Tran TTD
    Eur J Pharm Biopharm; 2021 Jul; 164():13-19. PubMed ID: 33887388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hot-Melt Extrusion: An Emerging Technique for Solubility Enhancement of Poorly Water-Soluble Drugs.
    Chivate A; Garkal A; Dhas N; Mehta T
    PDA J Pharm Sci Technol; 2021; 75(4):357-373. PubMed ID: 33608469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classification of solid dispersions: correlation to (i) stability and solubility (ii) preparation and characterization techniques.
    Meng F; Gala U; Chauhan H
    Drug Dev Ind Pharm; 2015; 41(9):1401-15. PubMed ID: 25853292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using Flory-Huggins phase diagrams as a pre-formulation tool for the production of amorphous solid dispersions: a comparison between hot-melt extrusion and spray drying.
    Tian Y; Caron V; Jones DS; Healy AM; Andrews GP
    J Pharm Pharmacol; 2014 Feb; 66(2):256-74. PubMed ID: 24192445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BCS class IV drugs: Highly notorious candidates for formulation development.
    Ghadi R; Dand N
    J Control Release; 2017 Feb; 248():71-95. PubMed ID: 28088572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug Solubilization by Means of a Surface-Modified Edible Biopolymer Enabled by Hot Melt Extrusion.
    Ong HJ; Pinal R
    J Pharm Sci; 2018 Jan; 107(1):402-411. PubMed ID: 29074381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in Polymer Design for Enhancing Oral Drug Solubility and Delivery.
    Ting JM; Porter WW; Mecca JM; Bates FS; Reineke TM
    Bioconjug Chem; 2018 Apr; 29(4):939-952. PubMed ID: 29319295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expanding the Application and Formulation Space of Amorphous Solid Dispersions with KinetiSol®: a Review.
    Ellenberger DJ; Miller DA; Williams RO
    AAPS PharmSciTech; 2018 Jul; 19(5):1933-1956. PubMed ID: 29846889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application and functional characterization of POVACOAT, a hydrophilic co-polymer poly(vinyl alcohol/acrylic acid/methyl methacrylate) as a hot-melt extrusion carrier.
    Xu M; Zhang C; Luo Y; Xu L; Tao X; Wang Y; He H; Tang X
    Drug Dev Ind Pharm; 2014 Jan; 40(1):126-35. PubMed ID: 23336809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Industrially feasible alternative approaches in the manufacture of solid dispersions: a technical report.
    Karanth H; Shenoy VS; Murthy RR
    AAPS PharmSciTech; 2006 Oct; 7(4):87. PubMed ID: 17233539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APPLICATION OF VARIOUS POLYMERS AND POLYMERS BASED TECHNIQUES USED TO IMPROVE SOLUBILITY OF POORLY WATER SOLUBLE DRUGS: A REVIEW.
    Muhammad Sarfraz R; Bashir S; Mahmood A; Ahsan H; Riaz H; Raza H; Rashid Z; Atif Raza S; Asad Abrar M; Abbas K; Yasmeen T
    Acta Pol Pharm; 2017 Mar; 74(2):347-356. PubMed ID: 29624239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges and Strategies in Thermal Processing of Amorphous Solid Dispersions: A Review.
    LaFountaine JS; McGinity JW; Williams RO
    AAPS PharmSciTech; 2016 Feb; 17(1):43-55. PubMed ID: 26307759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A combined mathematical model linking the formation of amorphous solid dispersions with hot-melt-extrusion process parameters.
    Schittny A; Ogawa H; Huwyler J; Puchkov M
    Eur J Pharm Biopharm; 2018 Nov; 132():127-145. PubMed ID: 30240820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple approaches for achieving drug solubility: an in silico perspective.
    Das T; Mehta CH; Nayak UY
    Drug Discov Today; 2020 Jul; 25(7):1206-1212. PubMed ID: 32353425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug carrier systems for solubility enhancement of BCS class II drugs: a critical review.
    Kumar S; Bhargava D; Thakkar A; Arora S
    Crit Rev Ther Drug Carrier Syst; 2013; 30(3):217-56. PubMed ID: 23614647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Building a better particle: Leveraging physicochemical understanding of amorphous solid dispersions and a hierarchical particle approach for improved delivery at high drug loadings.
    Schenck L; Mann AKP; Liu Z; Milewski M; Zhang S; Ren J; Dewitt K; Hermans A; Cote A
    Int J Pharm; 2019 Mar; 559():147-155. PubMed ID: 30654058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enabling superior drug loading in lipid-based formulations with lipophilic salts for a brick dust molecule: Exploration of lipophilic counterions and in vitro-in vivo evaluation.
    Sirvi A; Jadhav K; Sangamwar AT
    Int J Pharm; 2024 May; 656():124108. PubMed ID: 38604540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Producing Amorphous Solid Dispersions via Co-Precipitation and Spray Drying: Impact to Physicochemical and Biopharmaceutical Properties.
    Mann AKP; Schenck L; Koynov A; Rumondor ACF; Jin X; Marota M; Dalton C
    J Pharm Sci; 2018 Jan; 107(1):183-191. PubMed ID: 28711592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.